Publication Abstract Display | Type: Published Manuscript | Title: HIV infection heightens concurrent risk of functional dependence in persons with chronic
methamphetamine use. | Authors: Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin D, Ellis RJ, Grant I, Woods SP, and the TMARC Group | Year: 2013 | Publication: Journal of Addiction Medicine | Volume: 7 Issue: 4 Pages: 255-263 | Abstract:Objectives: The causes of disability among chronic methamphetamine (MA) users are
multifactorial. The current study examined the additive adverse impact of human
immunodeficiency virus (HIV) infection, a common comorbidity in MA users, on functional
dependence.
Methods: A large cohort of participants (N=798) stratified by lifetime MA dependence
diagnoses (i.e., MA+ or MA-) and HIV serostatus (i.e., HIV+ or HIV-) underwent comprehensive
baseline neuromedical, neuropsychiatric, and functional research evaluations, including
assessment of neurocognitive symptoms in daily life, instrumental and basic activities of daily
living, and employment status.
Results: Independent, additive effects of MA and HIV were observed across all measures of
functional dependence, independent of other demographic, psychiatric, and substance use
factors. The prevalence of global functional dependence increased in the expected stepwise
fashion across the cohort, with the lowest rates in the MA-/HIV- group (29%) and the highest
rates in the MA+/HIV+ sample (69%). The impact of HIV on MA-associated functional
dependence was moderated by nadir CD4 count, such that MA use was associated with greater
disability among those HIV-infected persons with higher, but not lower nadir CD4. Within the
MA+/HIV+ cohort, functional dependence was reliably associated with neurocognitive
impairment, lower cognitive reserve, polysubstance use, and major depressive disorder.
Conclusions: HIV infection confers an increased concurrent risk of MA-associated disability,
particularly among HIV-infected persons without histories of immune compromise. Directed
referrals, earlier HIV treatment, and compensatory strategies aimed at counteracting the effects
of low cognitive reserve, neurocognitive impairment, and psychiatric comorbidities on functional
dependence in MA+/HIV+ individuals may be warranted.Objectives: The causes of disability among chronic methamphetamine (MA) users are
multifactorial. The current study examined the additive adverse impact of human
immunodeficiency virus (HIV) infection, a common comorbidity in MA users, on functional
dependence.
Methods: A large cohort of participants (N=798) stratified by lifetime MA dependence
diagnoses (i.e., MA+ or MA-) and HIV serostatus (i.e., HIV+ or HIV-) underwent comprehensive
baseline neuromedical, neuropsychiatric, and functional research evaluations, including
assessment of neurocognitive symptoms in daily life, instrumental and basic activities of daily
living, and employment status.
Results: Independent, additive effects of MA and HIV were observed across all measures of
functional dependence, independent of other demographic, psychiatric, and substance use
factors. The prevalence of global functional dependence increased in the expected stepwise
fashion across the cohort, with the lowest rates in the MA-/HIV- group (29%) and the highest
rates in the MA+/HIV+ sample (69%). The impact of HIV on MA-associated functional
dependence was moderated by nadir CD4 count, such that MA use was associated with greater
disability among those HIV-infected persons with higher, but not lower nadir CD4. Within the
MA+/HIV+ cohort, functional dependence was reliably associated with neurocognitive
impairment, lower cognitive reserve, polysubstance use, and major depressive disorder.
Conclusions: HIV infection confers an increased concurrent risk of MA-associated disability,
particularly among HIV-infected persons without histories of immune compromise. Directed
referrals, earlier HIV treatment, and compensatory strategies aimed at counteracting the effects
of low cognitive reserve, neurocognitive impairment, and psychiatric comorbidities on functional
dependence in MA+/HIV+ individuals may be warranted. |
return to publications listing
|